Concepedia

Karen Berry

KB

Statistics

Publications

10

Citations

968

H-Index

10

Active since

1989

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Amgen (United States)

The University of Texas MD Anderson Cancer Center

Karen Berry is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and cell signaling.

Top concepts

Publications per year

1989–2010

10

Publications

10

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo et al. · Journal of Clinical Investigation · 1999 · 598 citations · Full text

Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells

Suyun Huang, Rakesh K. Singh, Keping Xie et al. · Cancer Immunology Immunotherapy · 1994 · 100 citations · Full text

, , +7

A <scp>d</scp> -Amino Acid Peptide Inhibitor of NF-κB Nuclear Localization Is Efficacious in Models of Inflammatory Disease

Sheri M. Fujihara, Jeffrey S. Cleaveland, Laura S. Grosmaire et al. · The Journal of Immunology · 2000 · 56 citations · Full text

Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis

James B. Atkinson, Richard L. Hoover, Karen Berry et al. · Atherosclerosis · 1989 · 56 citations

, , +11

Discovery of <i>N</i>-[2-[2-[[3-Methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-<i>N</i>-methyl-4- morpholineacetamide as a Novel and Potent Inhibitor of Inosine Monophosphate Dehydrogenase with Excellent in Vivo Activity

T. G. Murali Dhar, Zhongqi Shen, Junqing Guo et al. · Journal of Medicinal Chemistry · 2002 · 41 citations · Full text

, , +17

1–5 of 10